Kimberly-Clark readies EU remedies in bid for Kenvue deal, sources say

Kimberly-Clark is readying concessions to address ​EU antitrust concerns about ‌its bid for Tylenol maker Kenvue that could help ​it win approval ​for the $40 billion deal after ⁠a preliminary review,...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。